Turkish Journal of Medical Sciences
Volume 31

Number 6

Article 23

1-1-2001

Effect of Mg^{+2} Concentration in Mueller-Hinton Agar on the
Susceptibility of Pseudomonas Aeruginosa to Levofloxacin
NEZAHAT AKPOLAT
TUNCER ÖZEKİNCİ
SELAHATTİN ATMACA

Follow this and additional works at: https://journals.tubitak.gov.tr/medical
Part of the Medical Sciences Commons

Recommended Citation
AKPOLAT, NEZAHAT; ÖZEKİNCİ, TUNCER; and ATMACA, SELAHATTİN (2001) "Effect of Mg^{+2}
Concentration in Mueller-Hinton Agar on the Susceptibility of Pseudomonas Aeruginosa to Levofloxacin,"
Turkish Journal of Medical Sciences: Vol. 31: No. 6, Article 23. Available at: https://journals.tubitak.gov.tr/
medical/vol31/iss6/23

This Article is brought to you for free and open access by TÜBİTAK Academic Journals. It has been accepted for
inclusion in Turkish Journal of Medical Sciences by an authorized editor of TÜBİTAK Academic Journals. For more
information, please contact academic.publications@tubitak.gov.tr.

Turk J Med Sci
31 (2001) 585-586
© TÜB‹TAK

Nezahat AKPOLAT
Tuncer ÖZEK‹NC‹
Selahattin ATMACA

Department of Microbiology, Faculty of
Medicine, Dicle Universty, Diyarbak›r TURKEY

Letter to the Editor

Effect of Mg+2 Concentration in Mueller-Hinton
Agar on the Susceptibility of Pseudomonas
Aeruginosa to Levofloxacin

Received: February 09, 2001

The fluoroquinolone antibacterials are considered
valuable broad-spectrum agents. The class as a whole is
characterized by good antibacterial activity after oral
administration and by better performance against gramnegative organisms than gram-positive pathogens.
Quinolenes exert their antibacterial action via inhibition of
type II topoisomerase DNA gyrase, an essential bacterial
enzyme which alters the topology of double stranded
DNA within the cell. Levofloxacin is more potent against
gram-negative bacteria, and it exhibits better
antipseudomonal activity and greater oral bioavailability
(1-3).
Auckenthaler and colleagues reported that Mg
concentrations in media influence the suscetibility of some
gram-negative and gram-positive bacteria to nalidixic
acid, ciprofloxacin, enoxacin, norfloxacin, ofloxacin and
pefloxacin. We attempted to determine whether a higher
magnesium concentration in Mueller-Hinton agar (MHA)
influences the zone diameters of levofloxacin againts P.
aeruginosa strains in the disk diffusion method (4).
The magnesium concentration in BBL MHA (H2DWFX)
used throughout the study was 2.4 mg/L, having been
quantified by atomic absorption spectroscopy by Cooper
and colleagues (5). The magnesium ion concentration of
the medium was increased to 15 mg/L by the addition of
MgSO4, which gave a similar concentration to the 12.5
mg/L which was determined for BBL Mueller - Hinton

broth (Lot no: 1000E0DHWY). Fifteen P. aeruginosa
isolates were studied. The control strain used throughout
the study was P. aeruginosa ATCCC 27853. All P.
aeruginosa isolates were adjusted to an optical density of
0.5 McFarland standard (108 cfu/ml) with sterile saline
and then further diluted to achieve a final bacterial
concentration of 107 cfu/ml. The antibiotic susceptibilities
of P. aeruginosa isolates to levofloxacin (disk content 5
µg) were determined in both media. The depth of MHA
was c. 4mm. The procedure for the disk diffusion test
was that recommended by the NCCLS (6).
The result of the susceptibility testing of fifteen P.
aeruginosa isolates to levofloxacin on BBL MHA and
magnesium-supplemented MHA are shown in the Table.
Student’s t-test was used in the evaluation of the
difference between the susceptibilities of clinical isolates
of P. aeruginosa to levofloxacin on both media. All
Table:

Susceptibility of 15 P. aeruginosa isolates to levofloxacin
on media containing two different amounts of magnesium.
Mean (SEM) zone diameters (mm)

Antibiotics
Levofloxacin

MHA
(Mg 2.4 mg/L)

MHA with Mg supplement
(Mg 15mg/L)

22.8 (0.6)

20.4 (0.5)

P<0.005
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experiments were carried out twice. When magnesiumsupplemented MHA was used, the zone diameters of
levofloxacin with all isolates including the control
decreased (P<0.005). Similar experiments were carried
out for ceftazidime and no statistically significant
differences were observed for these on either medium
(P>0.05)(data not shown).
It is clear that the magnesium concentration in MHA
affects the activity of levofloxacin against P. aeruginosa.
The mechanism of impaired activity in the presence of
magnesium is unknown. Magnesium might interfere at at
least two levels, either on the outer membrane or at the
level of DNA-gyrase DNA interaction (5,7). These

observations may result in false reports of resistance to
levofloxacin and restrict the use of these antibiotics in the
treatment of P. aeruginosa infection. In addition, while
testing the susceptibility of quinolones, the concentration
of magnesium in the medium should be standardized
(8,9).
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